First nosocomial outbreak of SME-4-producing Serratia marcescens in South America.

Rev Argent Microbiol

Laboratorio de Bacteriología, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Facultad de Farmacia y Bioquímica, INFIBIOC, UBA, Argentina. Electronic address:

Published: November 2023

Carbapenemase-producing-Serratia marcescens isolates, although infrequent, are considered important nosocomial pathogens due to their intrinsic resistance to polymyxins, which limits therapeutic options. We describe a nosocomial outbreak of SME-4-producing S. marcescens in Buenos Aires city which, in our knowledge, represents the first one in South America.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ram.2023.02.002DOI Listing

Publication Analysis

Top Keywords

nosocomial outbreak
8
outbreak sme-4-producing
8
south america
8
sme-4-producing serratia
4
serratia marcescens
4
marcescens south
4
america carbapenemase-producing-serratia
4
carbapenemase-producing-serratia marcescens
4
marcescens isolates
4
isolates infrequent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!